Institutional review boards (IRBs) have the responsibility to ensure the protection of human-research subjects and are legally liable if they fail to do so.
Dr Majd Alsoubani joins Ethics Talk to discuss her article, coauthored with Drs Maya Nadimpalli and Shira Doron: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?”
There are nonpharmacological approaches to managing behavioral and psychological symptoms of dementia and the difficulties associated with evaluating and implementing these approaches.
Industry sponsorship of continuing medical education is controversial. A standard to adhere to is that before accepting any industry-sponsored education or incentive, a physician should form an independent evaluation of the product.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.